LEXINGTON, Mass. & SAN DIEGO--(BUSINESS WIRE)--Predictive Biosciences, an emerging molecular diagnostics company developing non-invasive diagnostic products for informed cancer management™, today announced that Peter Klemm, Ph.D., president and chief executive officer of Predictive Biosciences, will present at the 2008 Boston Biotech R&D Conference, at 1:00PM on October 22, 2008 at Harvard Medical School. This conference will bring luminaries from top academic institutions who have been instrumental in establishing the strong Boston biotech community together with executives from several of the area’s most promising emerging biopharmaceutical companies and leaders from the venture capital community and equity markets.
